PITTSBURGH–(BUSINESS WIRE)–Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, announced tha…
Author: Business Wire
GenSight Biologics annonce la validation de la demande d’autorisation de mise sur le marché (AMM) de LUMEVOQ® par l’Agence Européenne des Médicaments
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour le tr…
GenSight Biologics Reports Validation of LUMEVOQ® Marketing Authorisation Application (MAA) by European Medicines Agency
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Paris:SIGHT) (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative dis…
Aurinia Announces Outcome of AUDREY™ Clinical Trial in Dry Eye Syndrome
VICTORIA, British Columbia–(BUSINESS WIRE)–Aurinia Pharmaceuticals Inc. (Nasdaq: AUPH / TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company, today announced topline data from the Phase 2/3 AUDREY™ clinical study eva…
CHA Hollywood Presbyterian Medical Center Receives New Donation for Ophthalmic Technician Education Program
LOS ANGELES–(BUSINESS WIRE)–Southern California Eye Institute (SCEI) at CHA Hollywood Presbyterian Medical Center (CHA HPMC), a member of CHA Health Systems, a global network providing a full spectrum of dynamic healthcare services, received a gift f…
Global Ophthalmic Viscosurgical Devices Market (2020 to 2025) – Growths, Trends, and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmic Viscosurgical Devices Market – Growths, Trends, and Forecasts (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering. The ophthalmic viscosurgical devices market is expected to register a CAGR…
Worldwide Intraocular Lens Industry to 2025 – Accommodative IOL is Expected to Grow the Fastest – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Intraocular Lens Market – Growth, Trends, and Forecasts (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering. The global intraocular lens market is expected to witness a CAGR of 4.9% over the period, 2…
Trefoil Therapeutics to Present Update on Regenerative Treatments for Corneal Diseases
SAN DIEGO–(BUSINESS WIRE)–Trefoil Therapeutics to present update on its first-in-class, engineered FGF-1 regenerative treatments corneal diseases.
Lineage Cell Therapeutics to Host Expert Call Following OpRegen® Data Update at 2020 American Academy of Ophthalmology Meeting
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #AMD–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel cell therapies for unmet medical needs, will be hosting a call to discuss updated …
IVERIC bio Reports Third Quarter 2020 Operational Highlights and Financial Results
NEW YORK–(BUSINESS WIRE)–IVERIC bio today announced the financial and operating results for the fiscal quarter ended September 30, 2020 and provided a general business update.
Ocular Therapeutix™ and AffaMed Therapeutics Announce License Agreement and Collaboration for DEXTENZA® and OTX-TIC in Asia
BEDFORD, Mass.–(BUSINESS WIRE)—- $OCUL #OCUTX–Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases and conditions of the eye, today a…
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November 12
EMERYVILLE, Calif.–(BUSINESS WIRE)—- $NBY #Avenova–NovaBay Pharmaceuticals to announce third quarter 2020 financial results on November 12
New Study Shows Use of NeurOptics’ Automated Pupillometry Improves Triage for Patients with Traumatic Brain Injury
LAGUNA HILLS, Calif.–(BUSINESS WIRE)–New study shows NeurOptics’ automated pupillometer can improve triage and expedite treatment for patients with traumatic brain injury.
More Than 40% of Americans Say COVID-19 Has Influenced What Health Plan They Intend to Select During Open Enrollment
MINNETONKA, Minn.–(BUSINESS WIRE)–Many Americans said COVID-19 has influenced the health plan they intend to select during open enrollment, while the majority report they are interested in using a smartphone or laptop to access medical services, acco…
Synedgen Receives Supplemental NEI Funding to Identify Lead Development Candidate for Ocular Mustard Gas Injury Program
CLAREMONT, Calif.–(BUSINESS WIRE)–Synedgen Receives Supplemental NEI Funding to Identify Lead Development Candidate for Ocular Mustard Gas Injury Program
2020 Insights into Retinitis Pigmentosa (RP) – Epidemiology Forecast to 2030 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Retinitis Pigmentosa (RP) – Epidemiology Forecast to 2030” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the disease, historical and forecasted Retinitis Pigm…
Global Cataract Surgery Devices Market (2020 to 2025) – Growth, Trends, and Forecasts – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Cataract Surgery Devices Market – Growth, Trends, and Forecasts (2020 – 2025)” report has been added to ResearchAndMarkets.com’s offering. The Cataract Surgery Devices Market is projected to grow with a CAGR of 4.2% over t…
Global Optical Coherence Tomography for Ophthalmology Industry (2020 to 2027) – Market Trends and Drivers – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Optical Coherence Tomography (OCT) for Ophthalmology – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The publisher brings years of research experience to the 6th edit…
IVERIC bio to Participate in Upcoming Virtual Investor / Industry Conferences
NEW YORK–(BUSINESS WIRE)–IVERIC bio announced today that the Company will participate in upcoming virtual investor conferences in November.
Kala Pharmaceuticals to Report Third Quarter 2020 Financial Results and Host Conference Call
WATERTOWN, Mass.–(BUSINESS WIRE)–Kala Pharmaceuticals, Inc. (NASDAQ:KALA), a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye, today announced that it will report th…